Blood glucose was significantly increased in patients with Alzheimer's disease [46], likely reflecting impaired cerebral glucose uptake or insulin signaling, both key mechanisms implicated in Alzheimer's disease pathogenesis. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.